Literature DB >> 16324876

The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia.

V Brailo1, V Vucićević-Boras, A Cekić-Arambasin, I Z Alajbeg, A Milenović, J Lukac.   

Abstract

It is well known that cytokines play an important role in oral diseases. Furthermore, increased levels of interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) have been reported in patients with cancer and premalignant lesions such as oral lichen planus and oral submucous fibrosis. The aim of this study was to assess salivary IL-6 and TNF-alpha levels in 30 patients with histopathologically confirmed leukoplakia (age range 24-78, mean 52.3 years) in comparison to 34 controls (age range 27-79, mean 52 years). Salivary IL-6 and TNF-alpha were determined by enzyme linked immunoadsorbent assay. Statistical analysis was performed by use of Mann-Whitney test for independent samples and values lower than 0.05 were considered as significant (p<0.05). Significantly higher levels of salivary IL-6 and TNF-alpha in patients with oral leukoplakia when compared to healthy controls were found. The levels of salivary IL-6 and TNF-alpha did not correlate with the size of leukoplakia (lesions) nor with its localization regarding high and low risk sites for malignant transformation. Levels of salivary IL-6 and TNF-alpha were not influenced by smoking habits. We can conclude that increased salivary IL-6 and TNF-alpha might play a certain role in oral leukoplakia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16324876     DOI: 10.1016/j.oraloncology.2005.09.001

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  24 in total

Review 1.  Salivary biomarkers for clinical applications.

Authors:  Lei Zhang; Hua Xiao; David T Wong
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

2.  Identification of Salivary Proteomic Biomarkers for Oral Cancer Screening.

Authors:  Shigeo Ishikawa; Kenichi Ishizawa; Atsushi Tanaka; Hirohito Kimura; Kenichiro Kitabatake; Ayako Sugano; Kaoru Edamatsu; Shohei Ueda; Mitsuyoshi Iino
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

3.  Predictive value of salivary microRNA-320a, vascular endothelial growth factor receptor 2, CRP and IL-6 in Oral lichen planus progression.

Authors:  Minoo Shahidi; Soudeh Jafari; Mahmood Barati; Masoumeh Mahdipour; Mohammad Saeed Gholami
Journal:  Inflammopharmacology       Date:  2017-05-13       Impact factor: 4.473

4.  A review on salivary genomics and proteomics biomarkers in oral cancer.

Authors:  Franky D Shah; Rasheedunnisa Begum; Bhairavi N Vajaria; Kinjal R Patel; Jayendra B Patel; Shilin N Shukla; Prabhudas S Patel
Journal:  Indian J Clin Biochem       Date:  2011-08-09

5.  Determination of Salivary Myeloperoxidase, Immunoglobulin E, and Tumor Necrosis Factor-α after Complete Denture Insertion.

Authors:  Milena Kostic; Marko Igic; Tatjana Jevtovic Stoimenov; Ana Pejcic; Jana Pesic Stankovic
Journal:  Med Princ Pract       Date:  2019-03-08       Impact factor: 1.927

6.  Oral health care reduces the risk of postoperative surgical site infection in inpatients with oral squamous cell carcinoma.

Authors:  Jun Sato; Jun Goto; Ayako Harahashi; Tsubasa Murata; Hironobu Hata; Yutaka Yamazaki; Akira Satoh; Ken-ichi Notani; Yoshimasa Kitagawa
Journal:  Support Care Cancer       Date:  2010-03-16       Impact factor: 3.603

7.  Salivary IL-6 levels in oral leukoplakia with dysplasia and its clinical relevance to tobacco habits and periodontitis.

Authors:  Mohit Sharma; Indira Bairy; Keerthilatha Pai; Kapaettu Satyamoorthy; Shailendra Prasad; Barry Berkovitz; Raghu Radhakrishnan
Journal:  Clin Oral Investig       Date:  2010-06-19       Impact factor: 3.573

8.  Impairment of mesenchymal stem cells derived from oral leukoplakia.

Authors:  Zhihui Zhang; Jiangyuan Song; Ying Han; Dongdong Mu; Sha Su; Xiaoli Ji; Hongwei Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Expression of oral cytokines in HIV-infected subjects with long-term use of antiretroviral therapy.

Authors:  W Nittayananta; K Amornthatree; M Kemapunmanus; S Talungchit; H Sriplung
Journal:  Oral Dis       Date:  2013-05-30       Impact factor: 3.511

10.  Salivary and serum interleukin-6 levels in proliferative verrucous leukoplakia.

Authors:  Leticia Bagan; Guillermo T Sáez; M Carmen Tormos; Carlos Labaig-Rueda; Judith Murillo-Cortes; Jose V Bagan
Journal:  Clin Oral Investig       Date:  2015-08-09       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.